Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma
Active, not recruiting · NCT02758717 · Registry updated 2025-09-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma | classic Hodgkin lymphoma | Active, not recruiting | Phase 2 | 2025-09-09 | NCT02758717 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Academic and Community Cancer Research United | 13 |
| National Cancer Institute (NCI) | 3015 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University Hospital/Winship Cancer Institute | Atlanta | United States | 299 |
| Hackensack University Medical Center | Hackensack | United States | 308 |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone | New York | United States | 188 |
| M D Anderson Cancer Center | Houston | United States | 667 |
| Mayo Clinic | Rochester | United States | 664 |
| MedStar Georgetown University Hospital | Washington D.C. | United States | 204 |
| Ohio State University Comprehensive Cancer Center | Columbus | United States | 548 |
| Stanford Cancer Institute Palo Alto | Palo Alto | United States | 122 |
| Washington University School of Medicine | St Louis | United States | 895 |